GlassScriptPhysician profile
Eric I Contreras
NPI 1881383040
$959.52
in general payments reported to CMS, 2019-2025
20 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $191 · 2024: $504 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $220.76 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $123.92 | 2024-2025 | |
| Abbvie INC. | $102.31 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $66.91 | 2023-2024 | Xarelto |
| Exact Sciences Corporation | $61.76 | 2023-2025 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $57.21 | 2024-2025 | Nuzyra |
| Novo Nordisk INC | $43.83 | 2024-2025 | Ozempic, Rybelsus |
| Amgen INC. | $31.63 | 2023-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $30.51 | 2024 | Airsupra |
| Mylan Specialty L.P. | $30.00 | 2023-2024 | Yupelri |
| Depuy Synthes Sales INC. | $25.37 | 2025 | Orthovisc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.54 | 2025 | Jardiance |
| Pfizer INC. | $20.62 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $20.44 | 2023 | Rexulti |
| Lundbeck LLC | $19.68 | 2024 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.63 | 2025 | Inspire |
| Medtronic, INC. | $17.95 | 2023 | Intellis Adaptivestim |
| Sumitomo Pharma America, INC. | $15.38 | 2025 | Myfembree |
| Mannkind Corporation | $14.81 | 2024 | |
| Agios Pharmaceuticals, INC. | $14.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Contreras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.